SHEA/CDC Outbreak Response Training Program (ORTP) SHEA/CDC Outbreak Response Training Program (ORTP)
SHEA/CDC Outbreak Response
Training Program (ORTP)
Defending Against Superbugs: An Interactive Case Study Managing an “Outbreak” of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Hospital Setting

Defending Against Superbugs: An Interactive Case Study Managing an “Outbreak” of Carbapenem-Resistant Enterobacteriaceae (CRE) in a Hospital Setting

Time to Complete:
30 minutes


This simulation is designed to strengthen participants’ ability to develop an effective infection control approach in response to an outbreak of carbapenem-resistant Enterobacteriaceae in a hospital. Two case studies are presented, and participants will make clinical decisions that affect patient outcomes.



Priya Nori, MD
Assistant Professor, Department of Medicine
Medical Director, Antibiotic Stewardship Program
Albert Einstein College of Medicine
New York, NY

Dr. Priya Nori serves as Medical Director of the Antibiotic Stewardship Program (ASP) at the Montefiore Health System under Dr. Belinda Ostrowsky, Systems Director of Healthcare Epidemiology and Stewardship. She is an alumna of Johns Hopkins University and Albert Einstein College of Medicine, where she received the AMWA Glasgow-Rubin Achievement Award, and AOA. She completed her internship at Baylor College of Medicine, residency at the New York Presbyterian Hospital, Weill Cornell, and returned to Einstein/Montefiore for fellowship in infectious diseases. As medical director, Dr. Nori oversees operations at the Moses, Einstein, and Wakefield campuses. Her primary passion lies in medical education in ASP, infection prevention, and emerging infections. She leads ASP and ID educational initiatives throughout the health system and has pioneered programs to improve antibiotic prescribing at all levels. Her work on original decision-support tools and smartphone apps has been presented at IDSA and SHEA national meetings. With her microbiology colleagues, she has also published on the use of novel diagnostic technology for rapid microbe identification. She also serves on the IDSA Subcommittee for Antimicrobial Stewardship Curricula, and the CDC/SHEA Outbreak Response Training Program Education Committee. In 2015, Dr. Nori also helped pioneer the Montefiore OPAT (outpatient parenteral therapy) program in 2015, a transitional care model for patients receiving extended IV antibiotics. It is a niche outpatient ID service for patients with complex infections at high risk of readmission and treatment failure. The program observed a significant reduction in 30-day all cause readmissions within the first year and has expanded rapidly to fit the needs of the multifaceted Bronx population.  

Disclosed no relevant financial relationships

Christopher Pfeiffer, MD, MHS
Assistant Professor of Medicine
Oregon Health and Science University
Portland, OR

Christopher D. Pfeiffer, MD, MHS is board-certified in Infectious Diseases and Medical Microbiology. Since 2011, he has served as the Hospital Epidemiologist for the VA Portland Health Care System and an ID consultant at the Portland VA and Oregon Health & Science University (OHSU). In 2012, he became the Medical Director of Oregon’s newly established Drug Resistant Organism Prevention and Coordinated Regional Epidemiology (DROP-CRE) Network, a CDC-funded multidisciplinary project administered by the state health department (OHA). The goal of the DROP-CRE Network has been to develop and execute a coordinated regional approach to carbapenem-resistant Enterobacteriaceae (CRE) prevention, detection, and control in Oregon. Chris has also recently participated as a member on several SHEA initiatives (2016 Spring Conference Planning Committee, Education Committee, and the Stewardship Education Task Force) and in a national VA CRE Expert Advisory Group and is a site investigator for several multicenter VA infection prevention-related projects. Chris enjoys living in Oregon and spends most of his time outside of work raising 2 young children with his wife, Janice.

Disclosed no relevant financial relationships